Skip to main content
Heliyon logoLink to Heliyon
. 2021 Feb 23;7(3):e06351. doi: 10.1016/j.heliyon.2021.e06351

Anxiety and depression due to 2019 SARS-CoV-2 among frontier healthcare workers in Kenya

David Onchonga a,, Enoch Ngetich b, Wilbroda Makunda c, Pius Wainaina d, Diana Wangeshi e, Prémusz viktoria a
PMCID: PMC7901492  PMID: 33644428

Abstract

Background

The novel coronavirus disease continues to spread across the globe, causing anxiety and depression among healthcare workers.

Objectives

The current study aimed to determine the levels of anxiety and depression due to the coronavirus pandemic among healthcare workers in Kenya.

Methods

A total sample of 476 respondents participated. The 7-item Generalized Anxiety Disorder Scale (GAD-7) and Patient-Health Questionnaire (PHQ-9), together with a socio-demographic questionnaire, were applied. Stratified sampling was used. Data was analysed using the Statistical Package Programme for Social Science Version 23.0.0. Kruskal Wallis test and Mann-Whitney U test were employed to establish the differences in levels of anxiety and depression across socio-demographic characteristics. Ordinal logistic regression analysis was used to establish the predictors of levels of anxiety and depression, and associations were considered significant at p < 0.05.

Results

A total of 35.1% (n = 167) of the participants had mild anxiety, and 13.4% (n = 64) severe anxiety. Approximately 53.6% (n = 255) had mild depression while 9.2% (n = 44) had severe depression. The univariate analysis illustrated a statistical difference in anxiety levels in gender (p > 0.027), years of work experience (p = 0.005), and the cadre of respondents (p = 0.0028). Gender was statistically significant with the level of depression (p = 0.045). About 62.6% (n = 298) of healthcare workers had been trained, and only 9% (n = 43) were confident in managing COVID-19 cases. A large proportion, 98% (n = 458) had concerns about the availability of personal protective equipment.

Conclusion

The study findings indicated that the majority of healthcare workers had mild anxiety and depression. Female healthcare workers were more likely to experience severe anxiety and depression. Also, levels of anxiety and depression differed across different cadres of healthcare workers.

Keywords: Generalized anxiety disorder scale, Patient health questionnaire, Anxiety and depression scale, Mental health, Coronavirus


Generalized Anxiety Disorder Scale; Patient Health Questionnaire; Anxiety and Depression Scale; mental health; coronavirus

1. Introduction

Coronaviruses are a group of viruses belonging to the family of Coronaviridae, which infect both animals and humans [1]. Human coronaviruses can cause a mild disease similar to a common cold, while others cause severe diseases (Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome). Previously not identified in humans, a new coronavirus emerged in Wuhan, China in December 2019 [2], and within three months, the virus had spread across all continents [2, 3, 4, 5, 6, 7]. Considering its global threat, the World Health Organization (WHO) on January 30th, 2020 declared it a public health emergency of global concern [1, 8]. According to the WHO coronavirus Disease (COVID-19) dashboard posted on 13th February 2021 [9], there were 107,686,655 confirmed cases of COVID-19 disease with 2,368,571 deaths globally. Continuously, numerous countries are recording a large number of cases daily. Western Pacific has 1,524,130 cases, Europe 36,294,484 cases, South-Eastern Asia 13,165,612 cases, Eastern Mediterranean region 5,975,060 cases, the Americas 48,021,725 cases, and the African region 2,703,899 cases. In that regard, panic among members of the public is imminent, which increases mental stress and excruciating psychological distress [10].

Coronaviruses (CoVs) belong to a family of viruses responsible to cause respiratory infection in humans and enteritis in animals [11]. The 2019-nCoV (now commonly known as COVID-19) is a new coronavirus that has not been previously identified [12]. Most patients show mild to moderate, pneumonia-like symptoms, and may recover without special treatment [13]. However, older people and those with underlying medical conditions develop a severe acute respiratory infection. The initial case of COVID-19 disease demonstrated a pneumonia case of unknown cause after being assessed for viral pneumonia by testing of bronchoalveolar-lavage fluid using complete genome sequencing, cell cultures, and polymerase chain reaction (PCR) [14, 15, 16, 17, 18, 19].

The current COVID-19 disease has an evidently higher mortality rates in adults, unlike the human rhinoviruses and human adenoviruses which are prevalent in children [20, 21]. Frontier healthcare workers are mandated to control and manage epidemics based on their professional oaths of conduct and codes of regulation. Due to it's high infection rate, the WHO has recommended strategic infection prevention and control (IPC) measures among healthcare workers [22]. Ideally, these would reduce the rate of infection considering their high vulnerability to the virus [23, 24, 25, 26]. Furthermore, the public expects healthcare workers to reduce the burden amid the crisis. However, the crisis may be severe in developing countries where most health facilities are challenged with inadequate staffing, medical facilities, medical supplies, diagnostic equipment, and reagents. In that regard, the unprecedented influx of COVID-19 cases may further stretch the already inadequate human resource for health. Consequently, the healthcare workers may be working for long hours in stressful environments, which may lead to fatigue, anxiety, and depression. In China, a psychological impact report of the COVID-19 pandemic on the healthcare workers and the general public has provided insightful facts. Therefore, healthcare workers in developing countries like Kenya should expect similar effects and perhaps severe due to other challenges such as inadequate budgetary allocation to healthcare services, out-of-pocket spending for healthcare services, inadequacies in healthcare infrastructure and systemic challenges due to challenges in implementation of key policies set by the government [27, 28].

Although there have been studies on the prevalence of self-medication among healthcare workers [29] and the general public [30] before and during the COVID-19 pandemic attributed to the current pandemic, to the best of our knowledge and by the time of publication of this manuscript, there are no detailed studies on the levels of anxiety and depression among healthcare workers in Kenya due to the current COVID-19 pandemic. Therefore, this study aimed to evaluate the state of anxiety and depression due to the novel 2019 coronavirus disease among frontier healthcare workers in Kenya.

2. Materials and methods

2.1. Study design

A cross-sectional study design was employed in this study among 476 frontier healthcare workers actively involved in the management of the COVID-19 disease pandemic. Stratified sampling was used in this study. Firstly, different cadres of frontier healthcare workers were used as strata and in each stratum, an online questionnaire was sent to the healthcare professional online groups and platforms such as WhatsApp and Facebook. From each stratum, data was collected through random sampling of the received questionnaires until the required sample was reached. The shared questionnaire was anonymous to ensure data confidentiality and reliability.

2.2. Sample size determination

The sample size was determined by using the following formula: N = Zα2 P (1−P)/d2, where α was 0.05, Zα was 1.96 (at the 95% confidence level) and the estimated acceptable margin of error for proportion d was 0.05. The minimum sample would be 385 participants but we ended up recruiting 476 participants.

2.3. Data collection tools

The study adopted two validated questionnaires; the Generalized Anxiety Disorder Scale (GAD-7) to assess the level of anxiety and a Patient Health Questionnaire (PHQ-9) to assess the level of depression. A social-demographic section was added to capture information on; gender, age, level of education, years of experience, marital status, religion, the cluster of health facilities deployed, cadre, and on-job-training on COVID-19 disease.

The Generalized Anxiety Disorder (GAD-7) questionnaire is a validated seven-item, self-report anxiety questionnaire designed by Spitzer et al. [31] to assess the patient's health status within two (2) weeks. The items indicate the level an individual feels nervous, anxious or on edge, unable to control worrying, worrying too much about different things, having trouble relaxing, being restless, being irritable, and being afraid that something negative might happen. Scores from 0, 1, 2, or 3 were tagged on symptoms; ‘not at all’, ‘several days’, ‘more than half the days,’ and ‘nearly every day’, respectively. Then, the total scoresare presented from 0 to 21. Scores 5, 10, and 15 represented cut-off points for mild, moderate, and severe anxiety respectively [32, 33, 34]. When screening for an anxiety disorder, a score of greater than 10 is recommended for further evaluation [35].

The PHQ-9 is widely used as an open-access screening instrument for depression in different healthcare and community settings [36]. The instrument tallies nine questions from "0" (not at all) to "3" (nearly every day). The tool was developed as a fully self-administered version of the original PRIME-MD by Spitzer et al. [37]. PHQ-9 total scores for the nine items range from 0 to 27. The nine items include the experience of pleasure, feeling down, sleep disruption, energy levels, appetite, feeling of failure, trouble concentrating, speaking slowly or being fidgety, and having suicidal thoughts or self-harm over the past 2 weeks. The tool has been validated for use in primary care. Furthermore, aspects of the construct validity of the PHQ-9 have been documented in studies done both in medical settings and in the general population, exhibiting strong associations of the PHQ-9 depression severity score with diverse aspects of health-related quality of life [36, 38, 39].

2.4. Data analysis and presentation

Data was analysed using the Statistical Package Programme for Social Science Version 23.0.0 by IBM. Kruskal Wallis test and Mann-Whitney U test were used to establish the differences in levels of anxiety and depression across socio-demographic characteristics. Ordinal logistic regression analysis was applied to establish the predictors of the levels of anxiety and depression among healthcare workers and associations were considered significant at p < 0.05.

2.5. Ethical approvals

The approval to conduct this research was obtained from the Jaramogi Oginga Odinga Teaching and Referral Hospital Ethical Review Committee (IERC/JOOTRH/209/20). All the respondents were informed of the objectives of the study and were required to consent before enrolment into the study.

3. Results

Among the 476 respondents, half were female, the majority aged between 31-40 years old, and 45.6% (n = 217) had a bachelor's degree. Slightly above a third of respondents (37.8%) had worked for not more than five years. A large proportion of the healthcare workers were married (63.2%), Christians by religion (92.2%), and worked in County and Sub-county hospitals as shown in Table 1. About 62.6% (=298) of respondents in the study at the time of data collection had been trained on COVID-19 while 37.4% (n = 37.4) had not.

Table 1.

Socio-demographic characteristics of respondents.

Variable Frequency (n) Percent (%)
Gender
Male 231 48.5
Female 245 51.5
Total
476
100.0
Age
18–30 175 36.8
31–40 191 40.1
41–50 77 16.2
above 51 33 6.9
Total
476
100.0
Level of education
certificate 17 3.6
diploma 196 41.2
Higher diploma 46 9.7
Degree 217 45.6
Total
476
100.0
Years of experience
0–5 yrs. 180 37.8
6–10 yrs. 130 27.3
above 11 yrs. 166 34.9
Total
476
100.0
Marital status
single 175 36.8
married 301 63.2
Total
476
100.0
Religion
Christian 439 92.2
Muslim 32 6.7
others 5 1.1
Total
476
100.0
Place of work
dispensary 47 9.9
health Centre 60 12.6
county and sub-county hospital 188 39.5
administration 50 10.5
private health facility 78 16.4
Referral hospitals including university hospitals 53 11.1
Total 476 100.0

3.1. Level of anxiety

A majority of the healthcare workers in the survey had mild anxiety about the COVID-19 disease pandemic, 33.8% (n = 161) had moderate anxiety while 17.6% (n = 84) had moderately severe anxiety, and 13.4% (n = 64) had exhibited severe anxiety as shown in Table 2.

Table 2.

Levels of anxiety of respondents.

Anxiety Level Frequency (n) Percent (%)
Mild Anxiety 167 35.1
Moderate anxiety 161 33.8
Moderately severe anxiety 84 17.6
Severe anxiety 64 13.4
Total 476 100.0

3.2. Level of depression

Approximately 53.6% (n = 255) of healthcare workers had a mild form of depression, 26.9% (n = 128) moderate depression, 10.3% (n = 49) moderately severe depression, and 9.2% (n = 44) severe depression as indicated in Table 3.

Table 3.

Levels of depression of respondents.

Depression Level Frequency (n) Percent (%)
Mild depression 255 53.6
Moderate depression 128 26.9
Moderately severe depression 49 10.3
Severe depression 44 9.2
Total 476 100.0

3.3. Factors influencing frontier healthcare workers anxiety

As shown in Table 4, the univariate analysis illustrated a statistical difference in anxiety levels and the respondent's gender (p > 0.027), years of work experience, (p = 0.005), and the cadre (p = 0.0028). Univariate analysis of the association between socio-demographic characteristics and levels of depression had a statistical difference based on respondents' genders and the level of depression due to the COVID-19 disease pandemic (p = 0.045). There were no statistically significant differences across other socio-demographic characteristics based on the level of depression as shown in Table 5.

Table 4.

Univariate analysis of anxiety levels across sociodemographic variables.

Variable Levels of Anxiety
Total Statistics p-values
Mild anxiety Moderate anxiety Moderately severe anxiety Severe Anxiety
Gender
Male 93 (40.3%) 73 (31.6%) 41 (17.7%) 24 (10.4%) 231 4.897a
0.027
Female
74 (30.2%)
88 (35.9%)
43 (17.6%)
40 (16.3%)
245

Age
18–30 67 (38.3%) 53 (30.3%) 35 (20%) 20 (11.4%) 175 1.816b
0.612
31–40 68 (35.6%) 62 (32.5%) 29 (15.2%) 32 (16.8%) 191
41–50 19 (24.7%) 34 (44.2%) 16 (20.8%) 8 (10.4%) 77
Above 51
13 (39.4%)
12 (36.4%)
4 (12.1%)
4 (12.1%)
33
Level of Education
Certificate 8 (47.1%) 3 (17.6%) 3 (17.6%) 3 (17.6%) 17 7.812b
0.553
Diploma 73 (37.2%) 71 (36.2%) 30 (15.3%) 22 (11.2%) 196
Higher Diploma 16 (34.8%) 18 (39.1%) 8 (17.4%) 4 (8.7%) 46
Degree
70 (32.3%)
69 (31.8%)
43 (19.8%)
35 (16.1%)
217
Years of Experience
0-5 Yrs. 77 (42.8%) 51 (28.3%) 37 (20.6%) 15 (8.3%) 180 5.912b
0.005
6-10 Yrs. 40 (30.8%) 45 (34.6%) 18 (13.8%) 27 (20.8%) 130
Above 11 Yrs.
50 (30.1%)
65 (39.2%)
29 (17.5%)
22 (13.3%)
166
Marital Status
Single 72 (41.1%) 56 (32%) 26 (14.9%) 21 (12%) 175 4.818a
0.186
Married
95 (31.6%)
105 (34.9%)
58 (19.3%)
43 (14.3%)
301
Religion
Christian 159 (36.2%) 153 (34.9%) 73 (16.6%) 54 (12.3%) 439 14.575b
0.024
Muslim 6 (18.8%) 8 (25%) 9 (28.1%) 9 (28.1%) 32
Others
2 (40%)
0 (0%)
2 (40%)
1 (20%)
5
Place of Work
Dispensary 14 (29.8%) 19 (40.4%0 7 (14.9%) 7 (14.9%) 47 1.1b
0.9541
Health Centre 19 (31.7%) 23 (38.3%) 14 (23.3%) 4 (6.7%) 60
County &Sub County Hospital 70 (37.2%) 65 (34.6%) 29 (15.4%) 24 (12.8%) 188
Administration 16 (32%) 16 (32%) 14 (28%) 4 (8%) 50
Private Health Facility 29 (37.2%) 21 (26.9%) 13 (16.7%) 15 (19.2%) 78
Referral & university hospitals
19 (35.8%)
17 (32.1%)
7 (13.2%)
10 (18.9%)
53
Cadre
Administration 14 (42.4%) 8 (24.2%) 11 (33.3%) 0 (0%) 33 21.711b 0.0028
Public Health 28 (36.8%) 26 (34.2%) 11 (14.5%) 11 (14.5%) 76
Nursing Officer 56 (26.9%) 80 (38.5%) 37 (17.8%) 35 (16.8%) 208
Clinical Officer 24 (48%) 13 (26%) 7 (14%) 6 (12%) 50
Medical Officer 15 (30.6%) 12 (24.5%) 11 (22.4%) 11 (22.4%) 49
Lab Scientist and technologists 9 (42.9%) 8 (38.1%) 4 (19%) 0 (0%) 21
Pharmacist and technologists 15 (57.7%) 11 (42.3%) 0 (0%) 0 (0%) 26
Physiotherapists & technicians 6 (46.2%) 3 (23.1%) 3 (23.1%) 1 (7.7%) 13
a

Mann Whitney U Test.

b

Kruskal Wallis Rank Sum Test.

Table 5.

Univariate statistics for association between the sociodemographic characteristics and levels of depression.

Levels of Depression
Variable Mild depression Moderate depression Moderately severe depression Severe depression Total statistic p-values
Gender
Male 136 (58.6%) 56 (24.2%) 20 (8.7%) 19 (8.2%) 231 3.995a
0.045
Female
119 (48.6%)
72 (29.4%)
29 (11.8%)
25 (10.2%)
245
Age
18–30 89 (50.9%) 47 (26.9%) 19 (10.9%) 20 (11.4%) 175 3.102b
0.3761
31–40 109 (57.1%) 50 (26.2%) 17 (8.9%) 15 (7.9%) 191
41–50 37 (48.1%) 23 (29.9%) 9 (11.7%) 8 (10.4%) 77
above 51
20 (60.6%)
8 (24.2%)
4 (12.1%)
1 (3%)
33
Level of education
Certificate 11 (64.7%) 1 (5.9%) 3 (17.6%) 2 (11.8%) 17 0.184b
0.9801
Diploma 101 (51.5%) 62 (31.6%) 24 (12.2%) 9 (4.6%) 196
Higher diploma 22 (47.8%) 18 (39.1%) 2 (4.3%) 4 (8.7%) 46
Degree
121 (55.8%)
47 (21.7%)
20 (9.2%)
29 (13.4%)
217
Years of experience
0–5 yrs. 98 (54.4%) 48 (26.7%) 20 (11.1%) 14 (7.8%) 180 1.4993b
0.96
6–10 yrs. 68 (52.3%) 34 (26.2%) 13 (10%) 15 (11.5%) 130
above 11 yrs.
89 (53.6%)
46 (27.7%)
16 (9.6%)
15 (9%)
166
Marital status
single 98 (56%) 48 (27.4%) 15 (8.6%) 14 (8%) 175 1.5954a
0.66
married
157 (52.2%)
80 (26.6%)
34 (11.3%)
30 (10%)
301
Religion
Christian 239 (54.4%) 118 (26.9%) 43 (9.8%) 39 (8.9%) 439 5.1742b
0.522
Muslim 13 (40.6%) 10 (31.3%) 5 (15.6%) 4 (12.5%) 32
others
3 (60%)
0 (0%)
1 (20%)
1 (20%)
5
Place of work
dispensary 27 (57.4%) 10 (21.3%) 3 (6.4%) 7 (14.9%) 47 7.3373b
0.948
health Centre 33 (55%) 17 (28.3%) 5 (8.3%) 5 (8.3%) 60
county and sub county hospital 102 (54.3%) 49 (26.1%) 21 (11.2%) 16 (8.5%) 188
administration 22 (44%) 17 (34%) 5 (10%) 6 (12%) 50
private health facility 41 (52.6%) 23 (29.5%) 8 (10.3%) 6 (7.7%) 78
referral hospitals including university hospitals
30 (56.6%)
12 (22.6%)
7 (13.2%)
4 (7.5%)
53
Cadre
administration 18 (54.5%) 9 (27.3%) 4 (12.1%) 2 (6.1%) 33 31.3084b 0.052
public health 45 (59.2%) 16 (21.1%) 6 (7.9%) 9 (11.8%) 76
nursing officer 97 (46.6%) 64 (30.8%) 28 (13.5%) 19 (9.1%) 208
clinical officer 27 (54%) 14 (28%) 3 (6%) 6 (12%) 50
medical officer 27 (55.1%) 7 (14.3%) 8 (16.3%) 7 (14.3%) 49
Lab scientist and technologists 12 (57.1%) 9 (42.9%) 0 (0%) 0 (0%) 21
pharmacist and technologists 20 (76.9%) 6 (23.1%) 0 (0%) 0 (0%) 26
Physiotherapists and technicians 9 (69.2%) 3 (23.1%) 0 (0%) 1 (7.7%) 13
a

Mann Whitney U Test.

b

Kruskal Wallis Rank sum Test.

3.4. Ordinal logistic regression

Significant variables associated with the anxiety level included in the univariate analysis were subjected to ordinal regression analysis. Model fitting information illustrates that the final model used for regression analysis returned a significant value (χ2 = 52.317, DF = 24, p = 0.01). Parameter estimates revealed that for every unit increase in the level of anxiety; male respondents were 0.85 times less likely to experience anxiety as a result of COVID-19 than female (p = 0.013) as shown in Table 6.

Table 6.

Ordinal logistic regression analysis.

Variables Total (n) Sig A.O.R Lower Upper
Gender
Male 231 0.013 0.855 0.579 1.262
Female 245

1


Age-Groups
18–30 Years 175 0.094 2.325 0.867 6.236
31–40 Years 191 0.499 1.314 0.595 2.901
41–50 Years. 77 0.309 1.484 0.693 3.175
Above 51 Years. 33

1


Level of education
Certificate 17 0.349 0.626 0.234 1.669
Diploma 196 0.15 0.74 0.491 1.115
Higher Diploma 46 0.78 0.913 0.482 1.731
Degree 217

1


Years of Experience
0–5 Years. 180 0.092 0.521 0.244 1.113
6–10 Years. 130 0.421 1.265 0.714 2.241
Above 11 Years. 166

1


Marital Status
Single 175 0.181 0.747 0.486 1.146
Married 301

1


Religion
Christian 439 0.629 0.665 0.127 3.473
Muslim 32 0.575 1.657 0.284 9.679
Others 5

1


Workplace
Dispensary. 47 0.668 1.187 0.542 2.601
Health Centre. 60 0.359 1.402 0.681 2.884
County and sub county hospital. 188 0.88 1.046 0.581 1.884
Administration. 50 0.495 1.305 0.607 2.804
Private health facility. 78 0.158 1.639 0.825 3.257
Referral hospitals 53

1


Cadre of Respondents
Administration. 33 0.585 0.708 0.204 2.453
Public health 76 0.827 0.882 0.285 2.725
Nursing officer. 208 0.628 1.309 0.44 3.894
Clinical officer. 50 0.442 0.627 0.19 2.061
Medical officer. 49 0.5 1.513 0.454 5.035
Lab scientist and technologists. 21 0.672 0.75 0.199 2.834
Pharmacist and technologists. 26 0.069 0.288 0.075 1.104
Physiotherapists and technicians. 13 1

3.5. The perceived confidence level of frontier healthcare workers in managing COVID-19 cases

About half of the respondents were somewhat confident in managing COVID-19, and two-fifth were not confident at all. Only 9% (n = 43) of respondents in the survey were very confident in managing COVID-19 cases as indicated in Table 7.

Table 7.

Perceived confidence in managing COVID-19 cases.

Perceived confidence level in handling COVID-19 Frequency (n) Percentage (%)
Very confident 43 9.0
Somehow confident 234 49.2
Not confident at all 199 41.8
Total 476 100.0

4. Discussion

The current study's main aim was to assess anxiety and depression due to the novel 2019 coronaviruses disease among frontier healthcare workers. The study results indicated that the majority of healthcare workers across the mentioned cadres had mild anxiety (35.1%, n = 167) while those who had moderate-severe and severe anxieties were 17.6% and 13.4% respectively. Studies have indicated that during public health emergencies, frontier healthcare workers can experience numerous psychological effects, which can manifest as anxiety, fear, and panic, especially in highly impactful outbreaks such as COVID-19 disease [40, 41]. This would be a result of the novelty of the disease and the fact that frontier healthcare workers are the first line of response in such situations.

In the current study, gender, years of experience, and the cadre of respondents were statistically significant in terms of anxiety. Female participants were more anxious compared to their male counterparts, and the impact on nurses was severe compared to other cadres. The current study agrees with a similar study that has shown similar results [41]. Also, studies have attributed this to the level of interactions and roles played by women in society. Therefore, their duties at the health facilities may predispose them to the virus, which would endanger their families at home [42].

Nurses are the first frontline healthcare workers to interact with patients testing positive, which makes them more vulnerable. This not only poses a danger to them but also their peers, family members, and relatives with whom they interact and live with [43].

The current study reported that the number of patients testing positive for COVID-19 has exponentially risen, exerting pressure on the limited public health facilities and health personnel in the country. Also, the fear of incapacity to handle COVID-19 patients had elicited anxiety among healthcare workers, due to the nature and novelty of the virus. These findings agree with studies undertaken in China during the onset of the pandemic [10, 14].

In the current study, parameter estimates revealed that for every unit increase in the level of anxiety, male respondents were 0.855 times less likely to experience anxiety as a result of COVID-19 than females, similar to anxiety, female healthcare workers were more likely to be depressed as a result of the COVID-19 disease pandemic, and this agrees with another study which was done during epidemics of similar nature [44]. The observed differences can be attributed to gender-based roles for women at the household level. Available studies have also noted that anxiety symptoms positively predict later depressive symptoms [45, 46] and therefore there is a need to put measures in place once there is an indication of anxiety as this will greatly influence the development of depressive symptoms [47].

Also, the current study reported a relatively high number of frontier healthcare workers without confidence in managing COVID-19 cases. This would be attributed to the novelty of the disease. This finding is in agreement with other studies conducted during disease outbreaks and pandemics in different regions [48, 49], which have indicated that during the onset of pandemics, the healthcare workers are generally not well prepared especially in instances where the outbreaks are novel.

5. Conclusion

The findings of the current study indicates that the majority of healthcare workers had mild anxiety and depression. Female healthcare workers were more likely to experience severe anxiety and depression and the levels of anxiety and depression differed across different cadres of respondents. Therefore, there is a need for psychosocial support for frontline healthcare workers during the pandemics.

5.1. Strengths and limitations

The study utilized validated tools and methodologies in assessing the levels of anxiety and depression. Whereas the data was generally representative of the study population, the scope of the current study was limited to assessing anxiety and depression levels among frontier healthcare workers due to the novel 2019 coronaviruses disease.

Declarations

Author contribution statement

David Onchonga: Conceived and designed the experiments; Performed the experiments; Analyzed and interpreted the data; Wrote the paper.

Enoch Ngetich, Diana Wangeshi: Performed the experiments; Analyzed and interpreted the data.

Wilbroda Makunda, Pius Wainaina: Analyzed and interpreted the data; Wrote the paper.

Viktoria Prémusz: Contributed reagents, materials, analysis tools or data; Wrote the paper.

Funding statement

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data availability statement

Data will be made available on request.

Declaration of interests statement

The authors declare no conflict of interest.

Additional information

No additional information is available for this paper.

Acknowledgements

We acknowledge the efforts of the study participants.

References

  • 1.Lai C.-C., Shih T.-P., Ko W.-C., Tang H.-J., Hsueh P.-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int. J. Antimicrob. Agents. 2020;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Wang C., Horby P.P.W., Hayden F.F.G., Gao G.G.F. A novel coronavirus outbreak of global health concern. Lancet. 2020;395:470–473. doi: 10.1016/S0140-6736(20)30185-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Elsevier; 2020. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2001316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Gorbalenya A.E., Baker S.C., Baric R.S., de Groot R.J., Drosten C., Gulyaeva A.A. Severe acute respiratory syndrome-related coronavirus: the species and its viruses-a statement of the Coronavirus Study Group. BiorxivOrg. 2020 [Google Scholar]
  • 6.Holshue M.L., DeBolt C., Lindquist S., Lofy K.H., Wiesman J., Bruce H. First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 2020;382:929–936. doi: 10.1056/NEJMoa2001191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sohrabi C., Alsafi Z., O’neill N., Khan M., Kerwan A., Al-Jabir A. Elsevier; 2020. World Health Organization Declares Global Emergency: A Review of the 2019 Novel Coronavirus (COVID-19) [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.WHO WHO coronavirus disease (COVID-19) dashboard. World Heal. Organ. 2021 https://covid19.who.int/ [Google Scholar]
  • 10.Bao Y., Sun Y., Meng S., Shi J., Lancet L.L.-T. 2020 U. 2019-nCoV epidemic: address mental health care to empower society. Lancet. 2020;395:e37–e38. doi: 10.1016/S0140-6736(20)30309-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.WHO . 2020. Coronavirus Disease.https://www.who.int/health-topics/coronavirus#tabtab_1 [Google Scholar]
  • 12.Weiss S.R., Leibowitz J.L. Vol. 81. Academic Press Inc.; 2011. pp. 85–164. (Coronavirus Pathogenesis. Adv. Virus Res.). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.CDC . 2020. Frequently Asked Questions | CDC.https://www.cdc.gov/coronavirus/2019-ncov/faq.html#covid19-basics [Google Scholar]
  • 14.Zhu N., Zhang D., Wang W., Li X., Yang B., Song J. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727–733. doi: 10.1056/NEJMoa2001017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Lee S., Ruan S., Pan S., Lee T. JC-J of M, 2019 U. Performance of a multiplex PCR pneumonia panel for the identification of respiratory pathogens and the main determinants of resistance from the lower. J. Microbiol. Immunol. Infect. 2020;52:920–928. doi: 10.1016/j.jmii.2019.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Hung H.M., Yang S.L., Chen C.J., Chiu C.H., Kuo C.Y., Huang K.Y.A. Molecular epidemiology and clinical features of rhinovirus infections among hospitalized patients in a medical center in Taiwan. J. Microbiol. Immunol. Infect. 2019;52:233–241. doi: 10.1016/j.jmii.2018.08.009. [DOI] [PubMed] [Google Scholar]
  • 17.Lin G.L., Lu C.Y., Chen J.M., Lee P.I., Ho S.Y., Weng K.C. Molecular epidemiology and clinical features of adenovirus infection in Taiwanese children, 2014. J. Microbiol. Immunol. Infect. 2019;52:215–224. doi: 10.1016/j.jmii.2018.07.005. [DOI] [PubMed] [Google Scholar]
  • 18.Fuk-Woo Chan J., Kok K.-H., Zhu Z., Chu H., Kai-Wang To K., Yuan S. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Taylor Fr. 2020;9:221–236. doi: 10.1080/22221751.2020.1719902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Ren L.-L., Wang Y.-M., Wu Z.-Q., Xiang Z.-C., Guo L., Xu T. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. SampacEs. 2020 doi: 10.1097/CM9.0000000000000722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hung H., Yang S., Chen C., Chiu C. Elsevier; 2014. CK-J of M, 2019 U. Molecular Epidemiology and Clinical Features of Rhinovirus Infections Among Hospitalized Patients in a Medical center in Taiwan. [DOI] [PubMed] [Google Scholar]
  • 21.Lin G., Lu C., Chen J., Lee P. Elsevier; 2014. SH-J of M, 2019 U. Molecular Epidemiology and Clinical Features of Adenovirus Infection in Taiwanese Children. [DOI] [PubMed] [Google Scholar]
  • 22.Long Nicholas J. 2020. From Social Distancing to Social Containment: Reimagining Sociality for the Coronavirus Pandemic. [Google Scholar]
  • 23.Amaratunga C.A., O’Sullivan, PhD T.L., Phillips K.P., Lemyre L., O’Connor E., Dow D. Ready, aye ready? Support mechanisms for healthcare workers in emergency planning: a critical gap analysis of three hospital emergency plans. Am. J. Disaster Med. 2007;2:195–210. [PubMed] [Google Scholar]
  • 24.Klopfenstein M.L. Pandemic influenza and the duty to treat: the importance of solidarity and loyalty. Am. J. Bioeth. 2008;8:41–43. doi: 10.1080/15265160802318097. [DOI] [PubMed] [Google Scholar]
  • 25.Baron S., McPhaul K., Phillips S., Gershon R., Lipscomb J. Protecting home health care workers: a challenge to pandemic influenza preparedness planning. Am. J. Publ. Health. 2009;99(Suppl 2):S301–S307. doi: 10.2105/AJPH.2008.157339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Malm H., May T., Francis L.P., Omer S.B., Salmon D.A., Hood R. Ethics, pandemics, and the duty to treat. Am. J. Bioeth. 2008;8:4–19. doi: 10.1080/15265160802317974. [DOI] [PubMed] [Google Scholar]
  • 27.Onchonga D., MoghaddamHosseini V., Keraka M., Várnagy Á. Prevalence of fear of childbirth in a sample of gravida women in Kenya. Sex Reprod. Healthc. 2020;24:100510. doi: 10.1016/j.srhc.2020.100510. [DOI] [PubMed] [Google Scholar]
  • 28.Onchonga D., Várnagy Á., Keraka M., Wainaina P. Midwife-led integrated pre-birth training and its impact on the fear of childbirth. A qualitative interview study. Sex Reprod. Healthc. 2020;25:100512. doi: 10.1016/j.srhc.2020.100512. [DOI] [PubMed] [Google Scholar]
  • 29.Onchonga D., Omwoyo J., Nyamamba D. Assessing the prevalence of self-medication among healthcare workers before and during the 2019 SARS-CoV-2 (COVID-19) pandemic in Kenya. Saudi Pharmaceut. J. 2020 doi: 10.1016/j.jsps.2020.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Onchonga D. A Google Trends study on the interest in self-medication during the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharmaceut. J. 2020;28:903–904. doi: 10.1016/j.jsps.2020.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Spitzer R.L., Kroenke K., Williams J.B.W., Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch. Intern. Med. 2006;166:1092–1097. doi: 10.1001/archinte.166.10.1092. [DOI] [PubMed] [Google Scholar]
  • 32.Swinson R.P. The GAD-7 scale was accurate for diagnosing generalised anxiety disorder. Evid. Base Med. 2006;11:184. doi: 10.1136/ebm.11.6.184. [DOI] [PubMed] [Google Scholar]
  • 33.Williams N. The GAD-7 questionnaire. Occup. Med. (Chic Ill) 2014;64:224. [Google Scholar]
  • 34.Kroenke K., Spitzer R.L., Williams J.B.W. A brief measure for assessing generalized depression disorder. J. Gen. Intern. Med. 1999;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Plummer F., Manea L., Trepel D., McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen. Hosp. Psychiatr. 2016;39:24–31. doi: 10.1016/j.genhosppsych.2015.11.005. [DOI] [PubMed] [Google Scholar]
  • 36.Kocalevent R.D., Hinz A., Brähler E. Standardization of the depression screener Patient Health Questionnaire (PHQ-9) in the general population. Gen. Hosp. Psychiatr. 2013;35:551–555. doi: 10.1016/j.genhosppsych.2013.04.006. [DOI] [PubMed] [Google Scholar]
  • 37.Spitzer R.L., Kroenke K., Williams J.B.W. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. J. Am. Med. Assoc. 1999;282:1737–1744. doi: 10.1001/jama.282.18.1737. [DOI] [PubMed] [Google Scholar]
  • 38.Martin A., Rief W., Klaiberg A., Braehler E. Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. Gen. Hosp. Psychiatr. 2006;28:71–77. doi: 10.1016/j.genhosppsych.2005.07.003. [DOI] [PubMed] [Google Scholar]
  • 39.Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-9. J. Gen. Intern. Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Chua S.E., Cheung V., Cheung C., McAlonan G.M., Wong J.W., Cheung E.P. Psychological effects of the SARS outbreak in Hong Kong on high-risk health care workers. Can. J. Psychiatr. 2004;49:391–393. doi: 10.1177/070674370404900609. [DOI] [PubMed] [Google Scholar]
  • 41.Lai J., Ma S., Wang Y., Cai Z., Hu J., Wei N. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw. Open. 2020;3 doi: 10.1001/jamanetworkopen.2020.3976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Van D., McLaws M.L., Crimmins J., MacIntyre C.R., Seale H. University life and pandemic influenza: attitudes and intended behaviour of staff and students towards pandemic (H1N1) 2009. BMC Publ. Health. 2010;10:1–9. doi: 10.1186/1471-2458-10-130. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lancee W.J., Maunder R.G., Goldbloom D.S. Prevalence of psychiatric disorders among Toronto hospital workers one to two years after the SARS outbreak. Psychiatr. Serv. 2008;59:91–95. doi: 10.1176/ps.2008.59.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Styra R., Hawryluck L., SR . Elsevier; 2008. Impact on Health Care Workers Employed in High-Risk Areas during the Toronto SARS Outbreak. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Yahaya S.N. Prevalence and associated factors of stress, anxiety and depression among emergency medical officers in Malaysian hospitals. World J. Emerg. Med. 2018;9:178. doi: 10.5847/wjem.j.1920-8642.2018.03.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Van Baarsen B. Theories on coping with loss: the impact of social support and self-esteem on adjustment to emotional and social loneliness following a partner’s death in later life. J. Gerontol. Ser. B Psychol. Sci. Soc. Sci. 2002;57:33–42. doi: 10.1093/geronb/57.1.s33. [DOI] [PubMed] [Google Scholar]
  • 47.Gupta S., Prasad A.S., Dixit P.K., Padmakumari P., Gupta S., Abhisheka K. Survey of prevalence of anxiety and depressive symptoms among 1124 healthcare workers during the coronavirus disease 2019 pandemic across India. Med. J. Armed Forces India. 2020 doi: 10.1016/j.mjafi.2020.07.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Maunder R. The experience of the 2003 SARS outbreak as a traumatic stress among frontline healthcare workers in Toronto: lessons learned. Roy. Soc. Publ. Org. 2004;359:1117–1125. doi: 10.1098/rstb.2004.1483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Chan A.O.M., Huak C.Y. Psychological impact of the 2003 severe acute respiratory syndrome outbreak on health care workers in a medium size regional general hospital in Singapore. Acad. Oup. Com. 2004 doi: 10.1093/occmed/kqh027. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data will be made available on request.


Articles from Heliyon are provided here courtesy of Elsevier

RESOURCES